Consider the breast and lungs when determining thoracic imaging protocols

	Tweet

Carefully consider the radiation dose to the breast and lungs before deciding which CT protocol to use for thoracic imaging of individual patients, a new study cautions.

The study compared organ doses to the breast, lungs and pelvis using commonly used protocols and found a change in protocol could decrease breast radiation dose by more than 50 percent. “The highest doses to the breast skin and parenchyma were found with our standard thoracic CT protocol (120 kVp, variable 120-320 mA) and the protocol we use to assess for Pulmonary embolism in the general population (120kVp, variable 200-394 mA),” said Dr. Diana Litmanovich of Harvard Medical School in Boston, and the lead author of the study.

“We found the dose was reduced by more than half when we used our protocol for assessing Pulmonary embolism in pregnant or young patients,” (100 kVP, fixed 200 mA), said Dr. Litmanovich.

The standard thoracic CT and the Pulmonary embolism protocols also led to the highest radiation doses to the lung, Dr. Litmanovich said. The lung received the highest organ dose regardless of the protocol, while pelvic radiation was low regardless of the protocol, she said.

“Despite efforts to reduce radiation dose, irradiation of the breast and lung remain substantial,” said Dr. Litmanovich. “The study emphasizes the need for caution when we are planning our CT protocols,” she said.
###

The study is published in the October, 2011 American Journal of Roentgenology.

###

Contact: Keri Sperry

703-858-4315
American Roentgen Ray Society

RELATED STORIES:
Papillary lesions of the breast should be surgically excised to avoid missing a cancer   COX-2 blockers may curb breast cancer risk   BRCA1 Mutation Linked to Breast Cancer Stem Cells   Most recent mammography recommendations confuse public   Fox Chase scientists identify key protein players in hard-to-treat breast cancers   Estrogen receptor-alpha, breast cancer patients and tamoxifen response   New breast cancer genetics research from McGill University, Department of Human Genetics discussed   Late treatment with letrozole can reduce breast cancer recurrence risk   France to offer surgery if breast implants a risk   One-in-five women would consider breast removal   10,000-plus in US die for lack of cancer screens: CDC   For Women with Breast Cancer Gene, Psychological Factors Affect Choices about Risk-Reducing Surgery   Big Bias In Who Gets Screened for Breast Cancer   Breast cancer breakthrough as scientists discover faulty gene linked to half of all cases   The National Breast and Cervical Cancer Early Detection Program Recommendations   Cosmetic Breast Implants Do Not Interfere With Detecting Breast Cancer   Study Examines Power of Exercise to Prevent Breast Cancer   Social isolation ups risk of breast cancer death   Chemotherapy and breast cancer - side effects underestimated   New role discovered for breast cancer susceptibility gene BRCA1   Femara helps prevent the return of breast cancer   FDA Broadens Clearance For Agendia’s MammaPrint(R)

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]